Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dr. Kade Pharma is a long-standing German pharmaceutical company that specializes in the development and marketing of healthcare products, particularly in the fields of proctology, gynecology, and gastroenterology. The company markets the 'Panabiotics' brand, which features the Panabiotics Immun product line based on the AB21 probiotic formula. This formula consists of four specific bacterial strains (Lactobacillus plantarum and Pediococcus acidilactici) combined with Vitamin D to support the immune system and gut health. Dr. Kade partners with specialized biotech firms like AB-Biotics to bring scientifically-backed probiotic solutions to the European market. The company is headquartered in Berlin and maintains a significant presence in the German pharmacy retail sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Panabiotics.